Business Management
Business-in-Brief: January 2026
-
By
February 6, 2026
-
3 min
-
1
Merck acquires JSR Lifesciences for protein chromatography.
-
2
Velaris strengthens automation by acquiring Markes International.
-
3
Shimadzu set to buy Tescan for $678 million.
-
4
Specac buys Amax Precision for enhanced OEM capabilities.
-
5
Thermo Fisher and NVIDIA collaborate to boost lab automation.
-
Merck will acquire JSR Life Sciences' chromatography business to enhance the purification of monoclonal antibodies, with a deal expected to finalize by Q2 2026. Velaris has acquired Markes International for advancements in automated sample preparation in environmental analysis. Shimadzu is set to purchase Tescan for its expertise in electron microscopy for approximately $678 million by mid-2026. Specac has integrated Amax Precision for improved OEM manufacturing capabilities. Additionally, partnerships like the one between Thermo Fisher and NVIDIA aim to boost lab automation through AI, with several new product launches enhancing high-throughput and field performance.
-
1
Merck acquires JSR Lifesciences for protein chromatography.
-
2
Velaris strengthens automation by acquiring Markes International.
-
3
Shimadzu set to buy Tescan for $678 million.
-
4
Specac buys Amax Precision for enhanced OEM capabilities.
-
5
Thermo Fisher and NVIDIA collaborate to boost lab automation.
Listen Tab content
